ALS

Cara Murez WEDNESDAY, April 26, 2023 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis…

<!-- Name:DistributionId Value:8825425 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8825112 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

<!-- Name:DistributionId Value:8825434 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesThe Food and Drug Administration on Tuesday granted accelerated approval for Biogen's drug…

Vivien Williams: In this lab, Dr. Rosa Rademakers and her team have been on a quest to find a cause of two deadly diseases - Lou Gehrig's disease or ALS and frontotemporal dementia or FTD, which is a type of dementia unlike Alzheimer's…

<!-- Name:DistributionId Value:8823719 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8804517 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesThe Food and Drug Administration's independent panel of advisors on Wednesday voted against…

A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesThe Food and Drug Administration's independent panel of advisors on Wednesday declined to…